Navigation Links
Oridion Signs Strategic Development and Marketing Agreement with Global Healthcare Company

Oridion Microstream(R) Technology to be Incorporated Into Market Leader's Patient-Controlled Analgesia (PCA) Device

JERUSALEM and NEEDHAM, Massachusetts, January 15 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) today announced an agreement with a global healthcare company that is a market leader in medication infusion systems. Under this agreement, Oridion's Capnostream(TM) carbon dioxide (CO2) monitor using Microstream(R) capnography technology will be incorporated into a PCA infusion device at a future date, allowing hospital patients to control the flow of their pain medication within specified limits.

By enabling connectivity between the Capnostream and PCA device, clinicians will be able to monitor their patients' end tidal (CO2) levels. Clinicians using Microstream are more likely to detect respiratory depression than clinicians monitoring with pulse oximetry alone.(1) This is particularly important when administering potent pain medication.

The ability to monitor CO2 levels is vital. It can alert clinicians to episodes of hypoventilation as well as help them assess ventilation and treatment of asthma and chronic obstructive pulmonary disease (COPD) in patients. This is the reason why organizations, such as the Anesthesia Patient Safety Foundation (APSF)(2) and the American Society of Anesthesiologists (ASA)(3) recommend ventilatory monitoring when administering opiates and during procedural sedation. Patient-controlled analgesia systems are used in both environments.

"More and more hospital systems are becoming proactive about instituting policies to assure patient safety when potent drugs are used," said Gerry Feldman, president of Oridion. "It is good to see that the hospital community recognizes the importance of monitoring ventilation effectively, a necessity to safely eliminate unnecessary patient pain, a Joint Commission mandate. Our newest partner has selected Oridion, the world-wide leader in capnography monitoring, as an additional important step in their commitment to help hospitals reduce medication errors, improve patient safety and adhere to best clinical practices."

Further details regarding this agreement were not disclosed.

About Oridion

Oridion Systems Ltd. ( is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

(1) Jonathan B. Waugh, PhD, RRT, RPFT; Yulia Khodneva, MD; Chad A. Epps, MD, Monitoring to Improve Ventilation Safety during Sedation and Analgesia. Society for Technology in Anesthesia 2008.

(2) Anesthesia Patient Safety Foundation (APSF) Newsletter, Winter 2006-2007, Vol. 21, 4.

(3) American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology. 2002; 96(4):1004-17.

    For further Oridion information please contact:

    Alan Adler, Chairman and Chief Executive Officer,
    Walter Tabachnik, Chief Financial Officer,
    Elena Gerberg, Investor Relations;

    e-mail: ,
    website: ,
    phone: +972-2-589-9159,
    address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel.

SOURCE Oridion Systems Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Oridion Introduces New Smart Capnography System for Improved Patient Safety
2. Pot bellies linked to early signs of cardiovascular disease
3. MSU engineering team designs innovative medical device
4. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
5. Thomson Scientific Signs Multi-Year Agreement with The Council for Scientific and Industrial Research (CSIR)
6. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
7. A new technology for cancer screening listens for the signs of cancer
8. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
9. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
10. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
11. KARL LAGERFELD SAS Signs Global Eyewear License Agreement With Marchon Eyewear, Inc.
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: